This is an old revision of this page, as edited by SineBot (talk | contribs) at 16:27, 28 December 2011 (Signing comment by 109.149.157.19 - ""). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 16:27, 28 December 2011 by SineBot (talk | contribs) (Signing comment by 109.149.157.19 - "")(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)| This is the talk page for discussing improvements to the Biosafety level article. This is not a forum for general discussion of the article's subject. |
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1Auto-archiving period: 14 days  |
 | Medicine C‑class Low‑importance | |||||||||
| ||||||||||
Laboratory personnel have specific training in handling pathogenic and potentially lethal agents, and are supervised by competent scientists who are experienced in working with these agents. This is considered a neutral or warm zone.
This doesn't make much sense. What's considered a neutral to warm zone? The staff, the workplace, the safety level, the agent? And there is no explanation of what neutral to warm is. If it's referencing the safety level, level three is not going to be neutral, that'd make level 1 minus neutral, somehow. — Preceding unsigned comment added by 109.149.157.19 (talk) 16:26, 28 December 2011 (UTC)
Private BSL-3 facilities abound
Having worked and consulted in the DC area, RTP, Chicago, and at corporate sites around the eastern half of the US, I don't see any way to reasonably assemble a complete list of BSL-3 facilities. None of the ones I've worked at except USAMRIID are on this list; BSL-3 facilities are simply too common. Many vaccine manufacturing and testing facilities exist that can handle the pathogens requiring BSL-3, and most of them are not publicly advertised. The key point for BSL-3 is that treatment exists; if the treatment is derived from the living pathogen, industry will need this facility. While there isn't a West nile, Anthrax, SARS, or yellow fever testing facility on every corner, they are not uncommon enough to have the scarcity noted.
152.14.43.30 (talk) 16:51, 20 April 2011 (UTC) TWM
Similarly having worked in the UK industry designing such facilities, there are BSL-3 labs everywhere, and many, many are omitted from the list. BSL-4 is a different beast altogether and are much scarcer! --PopUpPirate (talk) 11:24, 3 September 2011 (UTC)
I agree. BSL-3 labs are everywhere and not particularly notable. I added some information from a a 2007 GAO report, showing there were 1356 CDC/USDA registered BSL3 facilities in the US at that time, but only 15 BSL-4. I would recommend that we delete the BSL-3's from the table. Patrikd (talk) 21:18, 9 December 2011 (UTC)
REDACTED
My apologies, I was wrong. Nevermind! Salvidrim (talk) 16:51, 21 August 2011 (UTC)
Noguchi Memorial Institute for Medical Research
Revision 456170207 by 197.255.96.5 (talk) added "Noguchi Memorial Institute for Medical Research" (NMIMR) to the External links section, but without any external link, citation, or indication of biosafety levels. I'm moving it to this talk page until the BSL can be confirmed.
The institute is in Ghana, is named after Hideyo Noguchi, and apparently has a BSL-2 or BSL-3 laboratory, or both. Some references:
- Addo, Phyllis; Quartey, Maxwell; Abbas, Mona; Adu-Addai, Benjamin; Owusu, Enid; Okang, Ishmael; Dodoo, Alfred; De Souza, Dziedom; Ankrah, Nii-Ayi; Ofori-Adjei, David (2008), "In-Vitro Susceptibility of Mycobacterium Ulcerans to Herbal Preparations", The Internet Journal of Tropical Medicine, 4 (2), ISSN 1540-2681, retrieved 2011-11-20. Mentions a level 2 biosafety laboratory at NMIMR.
- "Department of Virology". Noguchi Memorial Institute for Medical Research. University of Ghana. Retrieved 2011-11-20.
Good laboratory practices are strictly followed and special training provided for staffs who work in a biosafety level 3 (BSL 3) environment with related pathogens.
- Josephine NKETSIA-TABIRI, Ph.D (2003). Report on “The Survey on Programmes for Safe Use of Biotechnology/Biosafety And Existing Status of Biotechnology And Living Modified Organisms (LMOs) in Ghana” (PDF). National Review Workshop on “Surveys on Biotechnology, Biosafety Programmes and Related Legislation in Ghana”. UNEP-GEF, NBC, and BNARI. p. 44. ISBN 9988-8274-5-8. Retrieved 2011-11-20.
It is note-worthy that the NMIMR of UG has a level 3 pathogen-free laboratory.
85.23.32.64 (talk) 14:36, 20 November 2011 (UTC)
Missing BSL-3 Site
The Biosecurity Research Institute at Kansas State University in Manhattan Kansas has a BSL-3, ABSL-3 (animal BSL-3), BSL-3E (Enhanced BSL-3) and BSL-3Ag facility. It is located next to where the new BSL-4 facility is being built. It is mentioned in the article on the new facility but not listed as having its own BSL-3. This information was gleaned from a job posting on their website. So I assume it is reasonably accurate. DJBostrom (talk) 18:42, 3 December 2011 (UTC)
Genetically modified organisms are BSL-2?
Does anyone have a reference for the claim that "Genetically modified organisms have also been classified as level 2 organisms"? Seems like most iGEM projects are being done in BSL-1 labs. Patrikd (talk) 08:24, 9 December 2011 (UTC)
I deleted this statement, since it was clearly incorrect. According to the CDC, the NIH Guidelines are the key reference in assessing risk and establishing an appropriate biosafety level for work involving recombinant DNA molecules: http://oba.od.nih.gov/oba/rac/Guidelines/NIH_Guidelines.htm Patrikd (talk) 21:56, 9 December 2011 (UTC)
Categories: